These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21039054)

  • 1. Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients.
    Sailaja K; Rao DN; Rao DR; Vishnupriya S
    Asian Pac J Cancer Prev; 2010; 11(3):781-4. PubMed ID: 21039054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?
    Bedewy AM; El-Maghraby SM
    Hematology; 2013 Jul; 18(4):211-6. PubMed ID: 23394475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism analysis of CYP3A5 in myeloid leukemia.
    Liu TC; Lin SF; Chen TP; Chang JG
    Oncol Rep; 2002; 9(2):327-9. PubMed ID: 11836601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.
    Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Biswas NR; Gupta YK
    Pharmacol Res; 2017 Jun; 120():138-145. PubMed ID: 28330783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia.
    Adeagbo BA; Bolaji OO; Olugbade TA; Durosinmi MA; Bolarinwa RA; Masimirembwa C
    J Clin Pharm Ther; 2016 Oct; 41(5):546-51. PubMed ID: 27426203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients.
    Bajpai P; Tripathi AK; Agrawal D
    Mol Cell Biochem; 2010 Mar; 336(1-2):49-54. PubMed ID: 19823770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinib therapy?
    Harivenkatesh N; Kumar L; Bakhshi S; Sharma A; Kabra M; Velpandian T; Gogia A; Shastri SS; Gupta YK
    Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28367681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
    Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
    Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia.
    Sailaja K; Surekha D; Rao DN; Rao DR; Vishnupriya S
    Asian Pac J Cancer Prev; 2010; 11(2):461-4. PubMed ID: 20843134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphisms of CYP3A5 gene in acute leukemia patients and their role in chemotherapy and prognosis].
    Shen LJ; Chen FY; Wang T; Wang HR; Zhong JH; Han JY; Ouyang RR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):26-30. PubMed ID: 18315894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
    Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
    Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
    Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of
    Asadov C; Karimova N; Hasanova A; Bayramov B; Shirinova A; Alimirzoyeva Z
    Indian J Med Res; 2023 Aug; 158(2):151-160. PubMed ID: 37706370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation.
    Yanagimachi M; Naruto T; Tanoshima R; Kato H; Yokosuka T; Kajiwara R; Fujii H; Tanaka F; Goto H; Yagihashi T; Kosaki K; Yokota S
    Clin Transplant; 2010; 24(6):855-61. PubMed ID: 20030680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
    Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
    Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients.
    Elghannam DM; Ibrahim L; Ebrahim MA; Azmy E; Hakem H
    Hematology; 2014 Apr; 19(3):123-8. PubMed ID: 23683876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase C677T genetic polymorphisms and risk of leukaemia among the North Indian population.
    Hussain SR; Naqvi H; Raza ST; Ahmed F; Babu SG; Kumar A; Zaidi ZH; Mahdi F
    Cancer Epidemiol; 2012 Aug; 36(4):e227-31. PubMed ID: 22441130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia.
    Yaya K; Hind D; Meryem Q; Asma Q; Said B; Sellama N
    Tumour Biol; 2014 Nov; 35(11):10969-75. PubMed ID: 25087925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of CD38 gene polymorphism with pathogenesis of chronic myeloid leukemia].
    Li J; Zhu JF; Zhang W; Ma HZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):284-7. PubMed ID: 21518472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of ATM Gene Polymorphisms in Chronic Myeloid Leukemia - a Case Control Study from India.
    Gorre M; Mohandas PE; Kagita S; Cingeetham A; Vuree S; Jarjapu S; Nanchari S; Meka PB; Annamaneni S; Dunna NR; Digumarti R; Satti V
    Asian Pac J Cancer Prev; 2016; 17(2):815-21. PubMed ID: 26925685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.